Yuzhuo Pan

1.1k total citations
27 papers, 845 citations indexed

About

Yuzhuo Pan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yuzhuo Pan has authored 27 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Yuzhuo Pan's work include Pharmacogenetics and Drug Metabolism (5 papers), MicroRNA in disease regulation (5 papers) and Statistical Methods in Clinical Trials (4 papers). Yuzhuo Pan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), MicroRNA in disease regulation (5 papers) and Statistical Methods in Clinical Trials (4 papers). Yuzhuo Pan collaborates with scholars based in United States, China and Germany. Yuzhuo Pan's co-authors include Ping Zhao, Ai‐Ming Yu, Christian Wagner, Vicky Hsu, Vikram Sinha, Andrew E. Bruno, Zihua Hu, James Kalabus, Joseph A. Grillo and Mengyao Li and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Yuzhuo Pan

26 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuzhuo Pan United States 13 348 260 181 161 153 27 845
Stefan S. De Buck United States 11 540 1.6× 361 1.4× 146 0.8× 224 1.4× 215 1.4× 13 1.0k
Peng Duan China 17 466 1.3× 332 1.3× 262 1.4× 158 1.0× 102 0.7× 43 982
Camille Granvil United States 17 414 1.2× 303 1.2× 86 0.5× 59 0.4× 328 2.1× 34 1.0k
Douglas Ferguson United Kingdom 14 185 0.5× 142 0.5× 66 0.4× 183 1.1× 133 0.9× 28 615
Jeroen J. M. A. Hendrikx Netherlands 17 221 0.6× 527 2.0× 55 0.3× 193 1.2× 134 0.9× 57 939
Mohamed Elmeliegy United States 16 304 0.9× 583 2.2× 80 0.4× 289 1.8× 86 0.6× 52 944
Yvonne Lau United States 14 493 1.4× 638 2.5× 66 0.4× 257 1.6× 280 1.8× 30 1.3k
Emile G. Plise United States 17 493 1.4× 312 1.2× 46 0.3× 84 0.5× 115 0.8× 39 876
Anne-Charlotte Dubbelman Netherlands 17 386 1.1× 428 1.6× 48 0.3× 109 0.7× 79 0.5× 42 942
Diane D. Wang United States 14 191 0.5× 372 1.4× 48 0.3× 154 1.0× 102 0.7× 29 825

Countries citing papers authored by Yuzhuo Pan

Since Specialization
Citations

This map shows the geographic impact of Yuzhuo Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuzhuo Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuzhuo Pan more than expected).

Fields of papers citing papers by Yuzhuo Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuzhuo Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuzhuo Pan. The network helps show where Yuzhuo Pan may publish in the future.

Co-authorship network of co-authors of Yuzhuo Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yuzhuo Pan. A scholar is included among the top collaborators of Yuzhuo Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuzhuo Pan. Yuzhuo Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, Gautam U., Paz J. Vellanki, Yi Ren, et al.. (2024). FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations. The Oncologist. 29(8). 667–671. 10 indexed citations
2.
Pan, Yuzhuo, et al.. (2024). Efficiency bounds for bipartite information-thermodynamic systems. Physical review. E. 110(3). 34102–34102. 1 indexed citations
3.
Xia, Yu, et al.. (2023). Interspecific Competition as Affected by Nitrogen Application in Sweet Corn–Soybean Intercropping System. Agronomy. 13(9). 2268–2268. 5 indexed citations
4.
Gong, Yuqing, Kairui Feng, Yuzhuo Pan, et al.. (2022). Quantitative methods and modeling to assess COVID‐19‐interrupted in vivo pharmacokinetic bioequivalence studies with two reference batches. CPT Pharmacometrics & Systems Pharmacology. 11(7). 833–842. 1 indexed citations
5.
Jiang, Xiaojian, et al.. (2018). Bioequivalence Study Methods with Pharmacokinetic Endpoints for Topical Ophthalmic Corticosteroid Suspensions and Effects of Subject Demographics. Pharmaceutical Research. 36(1). 13–13. 10 indexed citations
6.
Hsueh, Chia‐Hsiang, Vicky Hsu, Yuzhuo Pan, & Ping Zhao. (2018). Predictive Performance of Physiologically-Based Pharmacokinetic Models in Predicting Drug–Drug Interactions Involving Enzyme Modulation. Clinical Pharmacokinetics. 57(10). 1337–1346. 16 indexed citations
7.
Pan, Yuzhuo, Vicky Hsu, Manuela Grimstein, et al.. (2016). The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives. The Journal of Clinical Pharmacology. 56(S7). S122–31. 39 indexed citations
8.
Tu, Mei‐Juan, Yuzhuo Pan, Jingxin Qiu, Edward Kim, & Ai‐Ming Yu. (2016). Impact and mechanistic role of MicroRNA-1291 on pancreatic tumorigenesis.. Journal of Clinical Oncology. 34(4_suppl). 243–243. 1 indexed citations
9.
Wagner, Christian, Yuzhuo Pan, Vicky Hsu, Vikram Sinha, & Ping Zhao. (2015). Predicting the Effect of CYP3A Inducers on the Pharmacokinetics of Substrate Drugs Using Physiologically Based Pharmacokinetic (PBPK) Modeling: An Analysis of PBPK Submissions to the US FDA. Clinical Pharmacokinetics. 55(4). 475–483. 78 indexed citations
10.
Leong, Rupert W., Pengfei Song, Qi Liu, et al.. (2015). Recommendations in a new drug application review for dose optimization to potentially improve gastrointestinal tolerability of a tyrosine kinase inhibitor.. Journal of Clinical Oncology. 33(15_suppl). 2574–2574. 1 indexed citations
11.
Wagner, Christian, Yuzhuo Pan, Vicky Hsu, et al.. (2014). Predicting the Effect of Cytochrome P450 Inhibitors on Substrate Drugs: Analysis of Physiologically Based Pharmacokinetic Modeling Submissions to the US Food and Drug Administration. Clinical Pharmacokinetics. 54(1). 117–127. 119 indexed citations
12.
Wei, Jun, Zhaohui Li, Chao Du, et al.. (2014). Abnormal expression of an ADAR2 alternative splicing variant in gliomas downregulates adenosine-to-inosine RNA editing. Acta Neurochirurgica. 156(6). 1135–1142. 12 indexed citations
13.
Bruno, Andrew E., et al.. (2012). miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes. BMC Genomics. 13(1). 44–44. 142 indexed citations
14.
Yu, Ai‐Ming & Yuzhuo Pan. (2012). Noncoding microRNAs: small RNAs play a big role in regulation of ADME?. Acta Pharmaceutica Sinica B. 2(2). 93–101. 48 indexed citations
15.
Rodrigues, Alice Cristina, Xin Li, Yuzhuo Pan, et al.. (2011). MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines. Biopharmaceutics & Drug Disposition. 32(6). 355–367. 45 indexed citations
16.
Saito, Seiichi, Yuzhuo Pan, Tsutomu Fujimura, et al.. (2008). Haptoglobin‐β chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer. International Journal of Cancer. 123(3). 633–640. 23 indexed citations
17.
Pan, Yuzhuo, Xueyuan Xiao, Dan Zhao, et al.. (2006). Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer. Asian Journal of Andrology. 8(1). 45–51. 23 indexed citations
18.
Pan, Yuzhuo, Xueyuan Xiao, Dan Zhao, et al.. (2005). [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].. PubMed. 85(45). 3172–5.
19.
Gao, Hongwen, Yulin Li, Shan Wu, et al.. (2005). Mass screening of prostate cancer in a Chinese population: the relationship between pathological features of prostate cancer and serum prostate specific antigen. Asian Journal of Andrology. 7(2). 159–163. 22 indexed citations
20.
Zhang, Ling, Xiaomeng Li, Wei‐Hua Wang, et al.. (2004). [Early diagnosis of prostate cancer using free/total prostate-specific antigen ratio with population-based screening data].. PubMed. 10(8). 582–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan S. De Buck Breakdown of academic impact, for papers by Peng Duan Breakdown of academic impact, for papers by Camille Granvil Breakdown of academic impact, for papers by Douglas Ferguson Breakdown of academic impact, for papers by Jeroen J. M. A. Hendrikx Breakdown of academic impact, for papers by Mohamed Elmeliegy Breakdown of academic impact, for papers by Yvonne Lau Breakdown of academic impact, for papers by Emile G. Plise Breakdown of academic impact, for papers by Anne-Charlotte Dubbelman Breakdown of academic impact, for papers by Diane D. Wang
Rankless by CCL
2026